Get the Stockscreener App
24.38
0.81%
0.185
Enovis Corp stock is traded at $24.38, with a volume of 344.84K.
It is up +0.81% in the last 24 hours and up +1.18% over the past month.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
See More
Previous Close:
$24.19
Open:
$24.42
24h Volume:
344.84K
Relative Volume:
0.34
Market Cap:
$1.40B
Revenue:
$2.25B
Net Income/Loss:
$-1.18B
P/E Ratio:
-1.178
EPS:
-20.6926
Net Cash Flow:
$19.92M
1W Performance:
-5.34%
1M Performance:
+1.18%
6M Performance:
-19.55%
1Y Performance:
-22.73%
1-Day Range:
$24.25
$25.03
1-Week Range:
$24.12
$26.65
52-Week Range:
$21.00
$36.82
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
24.36 | 1.39B | 2.25B | -1.18B | 19.92M | -20.69 |
ABT
Abbott Laboratories
|
86.56 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.86 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.81 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.76 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.13 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Resumed | William Blair | Outperform |
| Jan-06-26 | Initiated | BTIG Research | Buy |
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
A Look At Enovis (ENOV) Valuation After ESOP Shelf Registration For Up To 3,650,000 Shares - simplywall.st
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now? - AOL.com
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now? - The Motley Fool
ENOV Reiterated by BTIG -- Price Target Maintained at $39.00 - GuruFocus
Enovis (ENOV) earnings expected to grow: What to know ahead of next week's release - MSN
A Look at Enovis Corp (ENOV) After 7.1% Decline -- GF Value $49. - GuruFocus
Enovis (ENOV) director Rajiv Vinnakota receives 9,346-share equity grant - Stock Titan
Director A. Clayton Perfall gets Enovis (ENOV) stock grant, updates holdings - Stock Titan
What's Driving the Recent Buzz Around Enovis (ENOV) Stock - Kavout
Enovis shareholders approve amendment to 2020 incentive plan at annual meeting - Investing.com Nigeria
Enovis Shareholders Approve Expanded Incentive Plan and Board - TipRanks
Enovis (NYSE: ENOV) investors back 2020 incentive plan share and pay changes - Stock Titan
Is Enovis’ Improving Q1 2026 Results And Reaffirmed Outlook Altering The Investment Case For ENOV? - simplywall.st
Small-Cap Stock Picks: Hims & Hers Buy, Enovis & LifeStance Sell | May 2026News and Statistics - IndexBox
Does Enovis (ENOV) have the potential to rally 65.45% as Wall Street analysts expect? - MSN
Enovis (ENOV) CFO has 7,774 shares withheld to cover taxes - Stock Titan
Enovis (ENOV) Valuation Check After Reaffirmed 2026 Guidance And Solid First Quarter Results - simplywall.st
Enovis Q1 Growth And New Launches Refine Long Term Profit Story - Yahoo Finance
Earnings call transcript: Enovis Q1 2026 beats forecasts, stock fluctuates By Investing.com - Investing.com India
Does Enovis (ENOV) Have the Potential to Rally 65.45% as Wall Street Analysts Expect? - sharewise.com
Earnings call transcript: Enovis Q1 2026 beats forecasts, stock fluctuates - Investing.com
Enovis Corporation Q1 2026 earnings preview - MSN
Canaccord Genuity Keeps Their Buy Rating on Enovis (ENOV) - The Globe and Mail
Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Slump - simplywall.st
Enovis (ENOV) Is Up 16.3% After Reaffirming 2026 Outlook And Narrowing Losses – Has The Bull Case Changed? - Sahm
CCORF Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $50 - Moomoo
Enovis Corporation $ENOV Shares Sold by Vanguard Group Inc. - MarketBeat
Enovis Corporation 2026 Q1ResultsEarnings Call Presentation (NYSE:ENOV) 2026-05-10 - Seeking Alpha
Enovis Q1 Earnings Call Highlights - TradingView
Enovis Earnings Call Highlights Recon Strength, Caution - The Globe and Mail
A Quick Look at Today's Ratings for Enovis Corp(ENOV.US), With a Forecast Between $36 to $40 - Moomoo
Enovis (ENOV) Q1 2026 Earnings Transcript - AOL.com
Enovis Corporation (NYSE:ENOV) Q1 2026 Earnings Call Transcript - Insider Monkey
Enovis Is Maintained at Outperform by Evercore ISI Group - Moomoo
ENOV Maintained by Evercore ISI Group -- Price Target Raised to $36 - GuruFocus
Enovis Q1 2026 slides: earnings beat forecast, margins expand By Investing.com - Investing.com Australia
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.32%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):